About 75% of BC tumors are ER and PR positive and are associated with a more favorable prognosis as they respond to endocrine therapies (estrogen receptor modulators, aromatase inhibitors, or estrogen receptor inhibitors) [13]. The gene discussed is PGR; the disease is breast cancer.